| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.086 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |